Position
Chief Development Officer
Company
Cerenome, Inc.
HoustonManufacturingBiotechnologyHealth CareTherapeuticsPharmaceuticalHealth DiagnosticsDescription
Plus Therapeutics, Inc. announced the appointment of Eric J. Daniels, M.D., MBA, as Chief Development Officer, effective April 20, 2026
Quick answer
Plus Therapeutics Appoints Eric J. Daniels as Chief Development Officer (April 9, 2026). Cerenome, Inc. is based in Houston, Texas, United States.
- Who is the new Chief Development Officer at Cerenome, Inc?
- Cerenome, Inc. named Eric J. Daniels Chief Development Officer, announced April 9, 2026.
- What did Cerenome, Inc. announce on April 9, 2026?
- Plus Therapeutics, Inc. announced the appointment of Eric J. Daniels, M.D., MBA, as Chief Development Officer, effective April 20, 2026
- What does Cerenome, Inc. do?
- Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company developing targeted radiotherapeutics for difficult-to-treat cancers of the central nervous system with the potential to enhance clinical outcomes for...
- Where is Cerenome, Inc. based?
- Cerenome, Inc. is based in Houston, Texas, United States.
- Which similar companies made leadership changes around the same time?
- Pelthos Therapeutics (April 10, 2026), Abivax (April 12, 2026), NRx Pharmaceuticals (April 13, 2026) and Minerva Neurosciences (April 2, 2026) also announced leadership changes within 45 days of Cerenome, Inc.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Pelthos Therapeutics Appoints John M. Gay as Chief Financial Officer (April 10, 2026)
- ABIVAX Appoints Michael Nesrallah as Chief Commercial Officer (April 12, 2026)
- NRx Pharmaceuticals Appoints Glenn Tyson as Chief Commercial Officer (April 13, 2026)
- Minerva Neurosciences Appoints Dr. Sheila O’Connor as President and CEO (April 2, 2026)
- Vanda Pharmaceuticals Inc. Announces Resignation of Senior Executive (April 2, 2026)
- Juvisé Pharmaceuticals Appoints Renaud Sermondade as CEO (April 16, 2026)
Who to call at Cerenome, Inc., and when
A new leader at Cerenome, Inc. brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Cerenome, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cerenome, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cerenome, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cerenome, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Cerenome, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.